Company Data

Scinai Immunotherapeutics Ltd.

Ticker
SCNI
Current Price
$3.52 4.28%
Market Cap
$2.9M
Price Target
Refer to Report
Volume
5.8K
52wk Range
$2.23 - $8.92
Advanced Market Data

Overview

BiondVax Pharmaceuticals Ltd is engaged in the healthcare sector. Its main activity is the commercialization and manufacturing of flu vaccine. Its product is designed to provide multi-season and multi-strain protection against some human influenza virus strains, including both seasonal and pandemic flu strains. The company recently concluded two Phase I/II trials in which the multimeric-001 universal flu vaccine was shown to be safe and immunogenic.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy